The pandemic is a new setback for women in academia who already faced obstacles on the path to advancing their research and careers.
Pediatric Epilepsy
In recently published randomized controlled trials, fenfluramine (FFA) proved to be safe and effective in Dravet Syndrome.
The aim of this study is to describe children with epilepsy onset before 2 years of age, and to explore to what degree whole exome and whole genome sequencing (WES/WGS) can help reveal a molecular genetic diagnosis.
NAYZILAM® (midazolam) nasal spray, a rescue medicine manufactured by UCB, is experiencing a manufacturing delay. This shortage is expected to be temporary, lasting until the end of October 2020.
Growing observations strongly suggest that abnormal activation of critical inflammatory processes contributes to epileptogenesis. This paper reviews evidence conceptually supporting the potential role of inflammatory mechanisms and the relevant blood-brain barrier (BBB) disruption in epileptogenesis.
Sleep-related problems are major comorbidity in up to three-fourths of patients with DRE and sleep architecture is significantly affected particularly in the DRE group.
Previous studies have shown the effectiveness of manual?based treatment for psychogenic nonepileptic seizures (PNES), but access to mental health care still remains a problem, especially for patients living in areas without medical professionals who treat conversion disorder.
Find CURE news and upcoming events, such as SUDEP Action Day 2020, taking place on October 23.
Genetics, Pediatric Epilepsy
Dr. Heather Mefford is a current CURE Grantee who is as dedicated to driving science toward cures for epilepsy as she is to treating people in her clinical practice. As Associate Professor of Pediatrics at the University of Washington and attending physician at Seattle Children’s Hospital, Dr. Mefford is making an impact both in and out of the laboratory.
